NO842258L - Stabiliserte produkter for isoensymregulering. - Google Patents
Stabiliserte produkter for isoensymregulering.Info
- Publication number
- NO842258L NO842258L NO842258A NO842258A NO842258L NO 842258 L NO842258 L NO 842258L NO 842258 A NO842258 A NO 842258A NO 842258 A NO842258 A NO 842258A NO 842258 L NO842258 L NO 842258L
- Authority
- NO
- Norway
- Prior art keywords
- reagent according
- lactose
- net
- present
- reagent
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims description 55
- 108010044467 Isoenzymes Proteins 0.000 claims description 49
- 239000003381 stabilizer Substances 0.000 claims description 45
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 29
- 239000008101 lactose Substances 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 23
- 108090000790 Enzymes Proteins 0.000 claims description 23
- 230000000694 effects Effects 0.000 claims description 21
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 12
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 12
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 12
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 12
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 12
- 229930195725 Mannitol Natural products 0.000 claims description 12
- 239000000594 mannitol Substances 0.000 claims description 12
- 235000010355 mannitol Nutrition 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 230000000087 stabilizing effect Effects 0.000 claims description 7
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 6
- 125000003071 maltose group Chemical group 0.000 claims description 6
- 229910021645 metal ion Inorganic materials 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- -1 monosaccharide sugars Chemical class 0.000 claims 10
- 239000007864 aqueous solution Substances 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 3
- 239000010452 phosphate Substances 0.000 claims 3
- 239000004599 antimicrobial Substances 0.000 claims 1
- 238000001879 gelation Methods 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 239000000047 product Substances 0.000 description 8
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 7
- 238000007710 freezing Methods 0.000 description 7
- 230000008014 freezing Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229960001456 adenosine triphosphate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 102000014898 transaminase activity proteins Human genes 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50121383A | 1983-06-06 | 1983-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO842258L true NO842258L (no) | 1984-12-07 |
Family
ID=23992572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842258A NO842258L (no) | 1983-06-06 | 1984-06-05 | Stabiliserte produkter for isoensymregulering. |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP2596911B2 (ja) |
| AU (1) | AU583474B2 (ja) |
| CA (1) | CA1230300A (ja) |
| DK (1) | DK275184A (ja) |
| IL (1) | IL72030A0 (ja) |
| NO (1) | NO842258L (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1226795A (en) * | 1983-06-06 | 1987-09-15 | Michael K. Hoskins | Stabilized coagulation control products |
| CA1226794A (en) * | 1983-06-06 | 1987-09-15 | Michael K. Hoskins | Stabilized multiparameter control product |
| US4663295A (en) * | 1983-06-29 | 1987-05-05 | Ciba Corning Diagnostics Corp. | Estrogen-progesterone control reagents and methods for making same |
| JP2575648B2 (ja) * | 1986-04-24 | 1997-01-29 | 国際試薬株式会社 | クレアチンキナ−ゼの安定化方法 |
| IT1394539B1 (it) * | 2009-05-19 | 2012-07-05 | Sentinel Ch S P A | Uso di uno stabilizzante delle polimerasi per la liofilizzazione e la preparazione di kit pronti per l'uso |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4834912A (ja) * | 1971-09-09 | 1973-05-23 | ||
| JPS589688A (ja) * | 1981-07-06 | 1983-01-20 | Toyobo Co Ltd | 安定な酵素組成物 |
| JPS5865218A (ja) * | 1981-10-13 | 1983-04-18 | Kowa Co | 組織プラスミノーゲンアクチベーターの製造方法 |
| JPS58107178A (ja) * | 1981-12-22 | 1983-06-25 | Mitsui Toatsu Chem Inc | ベ−タ−ガラクトシダ−ゼ又はその複合体の安定な凍結乾燥品 |
| JPS58134991A (ja) * | 1981-12-28 | 1983-08-11 | Takeda Chem Ind Ltd | セラチオペプチタ−ゼの安定化法 |
| CA1226795A (en) * | 1983-06-06 | 1987-09-15 | Michael K. Hoskins | Stabilized coagulation control products |
| CA1226794A (en) * | 1983-06-06 | 1987-09-15 | Michael K. Hoskins | Stabilized multiparameter control product |
| US4663295A (en) * | 1983-06-29 | 1987-05-05 | Ciba Corning Diagnostics Corp. | Estrogen-progesterone control reagents and methods for making same |
-
1984
- 1984-05-02 CA CA000453361A patent/CA1230300A/en not_active Expired
- 1984-06-04 DK DK275184A patent/DK275184A/da not_active Application Discontinuation
- 1984-06-05 AU AU29085/84A patent/AU583474B2/en not_active Ceased
- 1984-06-05 IL IL72030A patent/IL72030A0/xx unknown
- 1984-06-05 NO NO842258A patent/NO842258L/no unknown
- 1984-06-06 JP JP59114690A patent/JP2596911B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1230300A (en) | 1987-12-15 |
| IL72030A0 (en) | 1984-10-31 |
| AU583474B2 (en) | 1989-05-04 |
| JP2596911B2 (ja) | 1997-04-02 |
| JPS606192A (ja) | 1985-01-12 |
| DK275184A (da) | 1984-12-07 |
| AU2908584A (en) | 1984-12-13 |
| DK275184D0 (da) | 1984-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4883762A (en) | Stabilized isoenzyme control products | |
| Beutler et al. | Erythrocyte glutathione reductase | |
| Bergmeyer et al. | Lactic dehydrogenase | |
| KOLOBOVA et al. | Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites | |
| Schlöndorff et al. | Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor α convertase | |
| Gracy et al. | Structural relations in aldolases purified from rat liver and muscle and Novikoff hepatoma | |
| Hill et al. | Functional Analysis of Conserved Histidines in ADP-Glucose Pyrophosphorylase fromEscherichia coli | |
| Wicker et al. | Effect of macromolecules on the structure of the mitochondrial inter-membrane space and the regulation of hexokinase | |
| Coffee et al. | Rat muscle 5'-adenylic acid aminohydrolase. Role of K+ and adenylate energy charge in expression of kinetic and regulatory properties. | |
| Gyldenholm et al. | The onset of photophosphorylation in chloroplasts isolated from developing bean leaves | |
| Fairbanks et al. | Phosphorylation and dephosphorylation of spectrin | |
| Ueki et al. | Regulation of phosphatase synthesis by orthophosphate in cultured tobacco cells | |
| US5496716A (en) | Stabilized creative kinase MB composition | |
| Hershey | Overview: phosphorylation and translation control | |
| NO842258L (no) | Stabiliserte produkter for isoensymregulering. | |
| US4684615A (en) | Stabilized isoenzyme control products | |
| Satoh et al. | Protein tyrosine kinase activity of eggs of the sea urchin Strongylocentrotus purpuratus: The regulation of its increase after fertilization | |
| Adams et al. | The distinctiveness of ATP: citrate lyase from Aspergillus nidulans | |
| CN101698880A (zh) | 血清钠离子酶法定量测定试剂盒及其制备方法和其检测方法 | |
| Kanamura | Postnatal changes in the localization of glucose 6‐phosphatase activity within the liver lobule of the mouse | |
| JP3619865B2 (ja) | 液体の安定なチオール活性化剤 | |
| Marangos et al. | Multiple Forms of Flounder Muscle Glyceraldehyde 3-Phosphate Dehydrogenase: SUBUNIT COMPOSITION, PROPERTIES, AND TISSUE DISTRIBUTION OF THE FORMS | |
| Flaks | [17] Nucleotide synthesis from 5-phosphoribosylpyrophosphate: Base+ PRPP⇄ nucleoside 5′-phosphate+ PP | |
| Snead et al. | d-Ribulose-1, 5-biphosphate carboxylase from Thiobacillus neapolitanus | |
| Marschke et al. | Purification and characterization of phosphofructokinase of Bacillus licheniformis |